Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s Growing CRAMS Sector Faces New Challenges

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - With an estimated annual growth of 25 percent, the Indian contract research and manufacturing services sector is attracting global attention as untapped potential for global pharmaceutical firms, but industry experts say working with India CRAMS brings several challenges

You may also be interested in...



CROs in Asian Giants India and China Create Alliance To Conduct Clinical Trials To Keep Pace With Exploding Demand

BEIJING - In response to rapidly accelerating demand for clinical drug research across Asia, India's GVK Biosciences and China's Excel PharmaStudies are crafting an alliance to jointly conduct trials in both countries

CROs in Asian Giants India and China Create Alliance To Conduct Clinical Trials To Keep Pace With Exploding Demand

BEIJING - In response to rapidly accelerating demand for clinical drug research across Asia, India's GVK Biosciences and China's Excel PharmaStudies are crafting an alliance to jointly conduct trials in both countries

India’s CRAMS Market Set To Leap To $2.46 Billion By 2010

MUMBAI - Low-cost and high-end formulation manufacturing capacity is propelling the growth of Indian contract manufacturers and the sector is poised to reach an estimated $2.46 billion by 2010. From the current level of $869 million, the contract research and manufacturing services sector will show an annual growth of 41.7 percent, according to a joint study by the Confederation of Indian Industries and the global consulting firm KPMG

UsernamePublicRestriction

Register

SC027449

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel